Risk-treatment paradox in use of statins
JAMA
.
2004 Jul 14;292(2):169; author reply 169.
doi: 10.1001/jama.292.2.169-a.
Authors
Carlos O Weiss
,
Ravi Varadhan
PMID:
15249563
DOI:
10.1001/jama.292.2.169-a
No abstract available
Publication types
Comment
Letter
MeSH terms
Aged
Cause of Death
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Life Expectancy
Risk
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors